-
Zaiding Medicine: Wei Weijia (Agamod) α Injection has been included in the national medical insurance drug catalog
Zaiding Pharmaceutical announced on December 13th that Wei Weijia& Reg; (Agamod) α Injection (Wei Weijia) has been included in the 2023 National Basic Medical Insurance, Work Injury Insurance, and M ... -
JD realizes online medical insurance payment for purchasing drugs
In May of this year, after the launch of the online drug purchase work for personal accounts of Beijing medical insurance, as the first platform to provide "online drug purchase medical insurance per ... -
JD has connected to 353 pharmacies for high-density coverage of "online medication purchase medical insurance individual account payment" services throughout Beijing
Starting from July 1st, the "Online Payment for Medical Insurance Personal Accounts for Drug Purchase" service in Beijing has been officially launched. insured individuals can use their medical insur ... -
JD's "Online Drug Purchase and Medical Insurance Personal Account Payment" has been integrated into over 410 pharmacies in Beijing
On July 10th, the Beijing Municipal Medical Insurance Bureau announced that the number of online drug purchase and medical insurance personal account payment services connected to pharmacies in the c ... -
BeiGene: Several new indications for commercial products have been included in the 2024 National Medical Insurance Drug Catalog
On November 28th, BeiGene announced that its independently developed anti-PD-1 antibody Baize'an (Trastuzumab Injection) and BTK inhibitor Baiyueze (Zebutinib Capsules) have been added to the new ver ... -
Novo Nordisk's world's first weekly insulin preparation, Novo Nordisk, has been included in the national medical insurance catalog
On November 28th, according to the latest announcement from the National Medical Security Administration, Novo Nordisk insulin injection (trade name Novo Life) has been included in the "National Basi ... -
AbbVie: Two new indications for Ruifu (Upatinib Extended Release Tablets) have been added to the national medical insurance catalog in China
On November 28th, AbbVie China announced that the two newly approved indications for the immune innovation product Ruifu (Upatinib Extended Release Tablets) in 2023 have entered the new version of th ... -
AstraZeneca's "breast cancer ADC miracle drug" DS-8201 entered the new version of medical insurance directory
[AstraZeneca's "breast cancer ADC miracle drug" DS-8201 entered the new version of the medical insurance directory] According to the 2024 national medical insurance directory released today, the repo ... -
Top 20 US stock transactions: Eli Lilly rises over 4%, Biden administration plans to include weight loss drugs in healthcare and subsidy programs
Top 20 US stock transactions: Eli Lilly rises over 4%, Biden administration plans to include weight loss drugs in healthcare and subsidy programs. Eli Lilly closed up 4.55%, with transactions of $5.1 ...